Record mula sa primary source
MateryalPagbabago sa trial registry
pembrolizumab · NCT05578664 update sa rehistro
katayuan: UNKNOWN → ACTIVE_NOT_RECRUITING; primary_completion: 2024-10 → 2028-03; completion: 2025-10 → 2031-02; enrollment: 81 → 85; mga bansa: {'total_sites': 1, 'us_sites': 0} → {'total_sites': 33, 'us_sites': 0}
Mahahalagang fact
- Na-file
- Okt 21, 2026, 03:21 PM
- Kaganapan
- Pagbabago sa trial registry
- Direksyon
- Neutral
- Kumpanya
MRKMSD- Asset
- pembrolizumab
- Pinagmulan
- ClinicalTrials.gov
- Kumpiyansa
- May source